StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

Browse signals
CMEBullishEarningsnews
High materiality8/10

CME Q3 Earnings Seen Rising on 22% International ADV Growth

Oct 19, 2026, 9:01 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

Solid Q3 volume momentum (international ADV +22%) supports fee revenue; consensus EPS uplift reinforces profitability visibility; mixed analyst targets suggest if CME delivers a beat or strong guidance, upside could materialize but risk remains from softer segments or guidance misses.

AI summary

What happened, with direct paths to the underlying reporting

CME Group is set to report Q3 earnings before the open on Oct 21, with expected EPS of $2.98 on $1.71B in revenue. International average daily volume rose 22% to 9 million contracts in Q3, underscoring stronger activity outside the U.S. While price targets among analysts vary (roughly $270–$337), a beat or strong guidance could spark a near-term upside for CME stock, given the volume momentum and cash-flow implications of higher global activity.

  • CME Q3 results due before market open Oct 21. EPS $2.98 expected.
  • Q3 international ADV up 22% to 9M contracts; rev estimate $1.71B.
  • Shares closed Friday at $293.87, up 1.5%; analysts show mixed targets.
  • Price targets range $270–$337 across firms; mixed near-term sentiment.
  • Volume growth supports fee-based revenue; earnings here could drive near-term move.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

Related signals

More source-backed signals connected by company or event